![SenoRx Logo](/news-release/logo/216615/0/216615.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A08&size=2)
SenoRx Completes Sale to C. R. Bard
July 06, 2010 09:15 ET
|
SenoRx, Inc.
IRVINE, Calif., July 6, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that the acquisition of the company by C. R. Bard, Inc. (NYSE:BCR) was completed today. Under the terms of...
![SenoRx Logo](/news-release/logo/216615/0/216615.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A08&size=2)
SenoRx Reports Continuing Revenue Growth and Strong Gross Margin in First Quarter 2010 on Strengthening International Market
May 05, 2010 17:35 ET
|
SenoRx, Inc.
IRVINE, Calif., May 5, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today reported financial results for its first quarter ended March 31, 2010. Revenue for the quarter increased 4.3 percent to...
![SenoRx Logo](/news-release/logo/216615/0/216615.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A08&size=2)
SenoRx to be Acquired by C. R. Bard for Approximately $213 Million
May 05, 2010 09:15 ET
|
SenoRx, Inc.
IRVINE, Calif., May 5, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced it has entered into a definitive merger agreement with C. R. Bard (NYSE:BCR) at a price of $11 per share, or...
SenoRx Announces First Quarter 2010 Conference Call and Webcast
April 08, 2010 10:00 ET
|
SenoRx, Inc.
IRVINE, Calif., April 8, 2010 (GLOBE NEWSWIRE) -- SenoRx Inc. (Nasdaq:SENO) today announced it will host its investor conference call to review its First Quarter 2010 financial results on Thursday,...
![SenoRx Logo](/news-release/logo/216615/0/216615.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A08&size=2)
SenoRx Board Appoints John T. Buhler as Chief Executive Officer and Member of Board of Directors
March 16, 2010 13:50 ET
|
SenoRx, Inc.
IRVINE, Calif., March 16, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) announced today that its Board of Directors appointed acting Chief Executive Officer John T. Buhler as the company's new...
![SenoRx Logo](/news-release/logo/216615/0/216615.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A08&size=2)
SenoRx Mourns Death of CEO Lloyd Malchow
March 15, 2010 16:41 ET
|
SenoRx, Inc.
IRVINE, Calif., March 15, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today with great sadness announced the death of its Chairman and Chief Executive Officer, Lloyd H. Malchow. Mr. Malchow...
![SenoRx Logo](/news-release/logo/216615/0/216615.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A08&size=2)
SenoRx Reports Record Revenues and Strong Gross Margin for Fourth Quarter and Fiscal Year 2009 With Continuing Positive Cash Flow
February 24, 2010 16:10 ET
|
SenoRx, Inc.
IRVINE, Calif., Feb. 24, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today reported financial results for its fourth quarter and fiscal year 2009. For the quarter ended December 31, 2009,...
![SenoRx Logo](/news-release/logo/216615/0/216615.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A08&size=2)
SenoRx Announces CEO to Take Medical Leave of Absence
February 08, 2010 08:00 ET
|
SenoRx, Inc.
IRVINE, Calif., Feb. 8, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that Chairman and Chief Executive Officer Lloyd H. Malchow is taking an indefinite medical leave of absence...
![SenoRx Logo](/news-release/logo/216615/0/216615.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A08&size=2)
SenoRx Announces Fourth Quarter and Fiscal Year 2009 Conference Call and Webcast
January 25, 2010 10:00 ET
|
SenoRx, Inc.
IRVINE, Calif., Jan. 25, 2010 (GLOBE NEWSWIRE) -- SenoRx Inc. (Nasdaq:SENO) today announced it will host its investor conference call to review its Q4/FY2009 financial results and guidance for 2010 on...
![SenoRx Logo](/news-release/logo/216615/0/216615.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A08&size=2)
SenoRx Found Not Liable for Patent Infringement
December 18, 2009 08:00 ET
|
SenoRx, Inc.
IRVINE, Calif., Dec. 18, 2009 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that a jury delivered a verdict in favor of SenoRx in a lawsuit brought by Hologic, Inc., Cytyc Corp., and...